| abstract |
The invention relates to a novel combination of a soft steroid, especially loteprednol, and at least one β2-adrenoceptor agonist for treating allergies and/or respiratory tract diseases simultaneously, sequentially or separately; to medicaments containing said combination, to methods for producing such medicaments and to the use of the novel combination for producing medicaments for the simultaneous, sequential or separate treatment of allergies and/or respiratory tract diseases. |